Latest AI and machine learning research in oncology/hematology for healthcare professionals.
KanCell is a deep learning model based on Kolmogorov-Arnold networks (KAN) designed to enhance cellu...
BACKGROUND: The electronic compensation (ECOMP) technique for breast radiation therapy provides exce...
One primary goal of precision medicine is to estimate the individualized treatment rules that optimi...
Accurate and fast histological diagnosis of cancers is crucial for successful treatment. The deep le...
BACKGROUND: Esophageal squamous cell carcinoma (ESCC) is a highly aggressive malignancy, and current...
Neoadjuvant chemotherapy (NAC) is a systemic and systematic chemotherapy regimen for breast cancer p...
Oral squamous cell carcinoma (OSCC) is the most common form of oral cancer, with increasing global i...
Monkeypox virus (MPXV), a zoonotic pathogen, re-emerged in 2022 with the Clade IIb variant, raising ...
Pancreatic neuroendocrine tumors (PanNETs) are a heterogeneous group of neoplasms that include tumor...
The applications of artificial intelligence (AI) and deep learning (DL) are leading to significant a...
BACKGROUND: Pancreatic ductal adenocarcinoma (PDAC) is a major public health concern, ranking as the...
Lung cancer is a devastating public health threat and a leading cause of cancer-related deaths. Ther...
INTRODUCTION: T-cell receptors (TCRs) play a critical role in the immune response by recognizing spe...
The drug combination is an attractive approach for cancer treatment. PARP and kinase inhibitors have...
BACKGROUND: The prognostic prediction of pancreatic ductal adenocarcinoma (PDAC) remains challenging...
This white paper examines the potential of pioneering technologies and artificial intelligence-drive...
AIM: o point out how novel analysis tools of AI can make sense of the data acquired during OL and OC...
The identification and categorization of circulating tumor cells (CTCs) in peripheral blood are impe...
PURPOSE: Identification of the molecular subtypes in breast cancer allows to optimize treatment stra...
BACKGROUND: Hematologic changes after splenectomy and hyperthermic intraperitoneal chemotherapy (HIP...
Hormone receptor-positive (HR+)/human epidermal growth factor receptor 2-negative (HER2-) breast can...